Main Article Content


Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Type 2 diabetes results from the body’s ineffective use of insulin. Type 2 diabetes comprises most people with diabetes around the world and is associated with various complications such as diabetic , , nephropathy, cardio vascular diseases, depression, dementia, sexual dysfunction etc. classified as , or blue-green algae which has been used for centuries as a food source in other countries. is also being promoted to prevent, treat, or cure several conditions, including high cholesterol, hypertension, diabetes, depression, viral hepatitis, and malnutrition. A few assertions have been tested, but most trials have been small, poorly designed, or inconclusive. Statins suppress the enzyme HMG-CoA reductase via pathway. The health advantage of HMG-CoA reductase inhibitors is believed to expand behind their cholesterol lowering effects. Such effects of statins incorporate complimentary effects on endothelial function, systemic inflammation and oxidative stress. The above-mentioned effects were predicted to decrease the risk of diabetes, even though statins are supported by most patients, some study suggested it is affiliated with new onset of diabetes . Despite dispute discoveries, many studies suggest that different statins may relay distinct possibility of diabetes. The problem is, there's little or no scientific evidence to back up such claims. this review is under taken to the potential benefits if and statin in management of type 2 diabetes and its complications. Many previous studies were thoroughly, and it was found that combination of and statin is found to reduce the diabetes and its complications.


Diabetic complication spirulina statin Type 2 diabetes

Article Details

How to Cite
Anand Vijaya Kumar P R, Kokul Rajan P, Seema A, & Balashanmugam K. (2020). Statin and Spirulina: Will it be an Effective combination in Management of Type 2 Diabetes and it’s Complications. International Journal of Research in Pharmaceutical Sciences, 11(4), 6589-6594.